ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

FDA News: Rule On Youth Tobacco Sales In Effect Feb. 28

February 21, 1997

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005

NCI Continues Making Improvements In Contract Management

May 22, 1981